KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ: 307750)
4,225.00
+110.00 (2.67%)
Sep 12, 2024, 3:19 PM KST
KUKJEON PHARMACEUTICAL Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7,054 | 10,992 | 21,546 | 19,099 |
Short-Term Investments | 10,000 | 15,000 | 45,000 | 20,160 |
Trading Asset Securities | 35,354 | 38,840 | 28,425 | - |
Cash & Short-Term Investments | 52,408 | 64,833 | 94,971 | 39,259 |
Cash Growth | -14.78% | -31.73% | 141.91% | - |
Accounts Receivable | 33,028 | 26,850 | 21,923 | 20,015 |
Other Receivables | 342.82 | 1,964 | 867.93 | 194.62 |
Receivables | 33,691 | 29,065 | 23,403 | 20,409 |
Inventory | 25,832 | 27,563 | 20,209 | 16,207 |
Prepaid Expenses | 393.88 | 494.91 | 246.48 | 143.8 |
Other Current Assets | 1,272 | 2,036 | 4,064 | 896.09 |
Total Current Assets | 113,596 | 123,992 | 142,893 | 76,915 |
Property, Plant & Equipment | 89,110 | 86,060 | 46,118 | 24,026 |
Long-Term Investments | 3,902 | 4,364 | 3,173 | 3,493 |
Goodwill | 420.39 | 420.39 | 420.39 | - |
Other Intangible Assets | 909.41 | 971 | 903.51 | 422.37 |
Long-Term Deferred Tax Assets | 1,861 | 1,964 | - | 794.9 |
Other Long-Term Assets | 7,180 | 7,090 | 2,379 | 517.79 |
Total Assets | 220,699 | 225,102 | 196,097 | 106,989 |
Accounts Payable | 16,797 | 11,693 | 9,474 | 10,989 |
Accrued Expenses | 326.62 | 289.73 | 178.99 | 83.02 |
Short-Term Debt | 7,904 | 15,224 | 7,883 | 5,133 |
Current Portion of Long-Term Debt | 41,255 | 36,802 | 26,015 | 1,457 |
Current Portion of Leases | 281.87 | 236.17 | 147.15 | 124.88 |
Current Income Taxes Payable | - | - | - | 1,057 |
Current Unearned Revenue | 17.58 | 35.16 | - | - |
Other Current Liabilities | 28,166 | 35,542 | 26,993 | 3,007 |
Total Current Liabilities | 94,748 | 99,823 | 70,691 | 21,852 |
Long-Term Debt | 24,447 | 26,183 | 25,091 | 942.84 |
Long-Term Leases | 367.55 | 334.14 | 202.84 | 193.97 |
Long-Term Deferred Tax Liabilities | 10.45 | 10.45 | 1,365 | - |
Other Long-Term Liabilities | 1,271 | 1,296 | 6,425 | 849.76 |
Total Liabilities | 120,844 | 127,646 | 103,774 | 23,838 |
Common Stock | 4,907 | 4,907 | 4,907 | 4,907 |
Additional Paid-In Capital | 62,139 | 62,386 | 62,386 | 62,397 |
Retained Earnings | 32,148 | 29,129 | 24,305 | 15,848 |
Treasury Stock | -1.16 | -1.16 | -1.16 | -1.16 |
Comprensive Income & Other | -0 | 0 | 0 | 0 |
Total Common Equity | 99,193 | 96,422 | 91,597 | 83,150 |
Minority Interest | 662.31 | 1,035 | 725.74 | - |
Shareholders' Equity | 99,855 | 97,456 | 92,323 | 83,150 |
Total Liabilities & Equity | 220,699 | 225,102 | 196,097 | 106,989 |
Total Debt | 74,256 | 78,780 | 59,339 | 7,852 |
Net Cash (Debt) | -21,848 | -13,947 | 35,632 | 31,407 |
Net Cash Growth | - | - | 13.45% | - |
Net Cash Per Share | -402.33 | -284.24 | 695.44 | 712.02 |
Filing Date Shares Outstanding | 49.07 | 49.07 | 49.07 | 49.07 |
Total Common Shares Outstanding | 49.07 | 49.07 | 49.07 | 49.07 |
Working Capital | 18,847 | 24,169 | 72,202 | 55,063 |
Book Value Per Share | 2021.49 | 1965.01 | 1866.70 | 1694.56 |
Tangible Book Value | 97,863 | 95,030 | 90,274 | 82,728 |
Tangible Book Value Per Share | 1994.39 | 1936.66 | 1839.72 | 1685.95 |
Land | 20,224 | 19,837 | 15,613 | 3,997 |
Buildings | 37,365 | 36,673 | 11,300 | 8,252 |
Machinery | 29,887 | 22,297 | 11,051 | 7,554 |
Construction In Progress | 623.29 | 6,407 | 13,388 | 9,214 |
Source: S&P Capital IQ. Standard template. Financial Sources.